About us
Synmedix is a platform technology company developing next generation antibiotics to treat drug-resistant infections.
In partnership with McMaster University, Synmedix aims to develop a first-in-class treatment for diabetic foot ulcer infection.
Program engagement
Synmedix
Leadership:
Eric Brown
Founder and CEO
Stage:
- Idea Stage
Sector:
- Life Sciences
Subsector:
- Drug / Therapeutic